Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Xrp 9881
2. Xrp-9881
3. Xrp9881
1. Larotaxel [inn]
2. 156294-36-9
3. Xrp-9881
4. Xrp9881
5. Twq8k8a81y
6. Benzenepropanoic Acid, Beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (1s,2s,4s,7r,8ar,9as,10ar,12as,12br)-7,12a-bis(acetyloxy)-1-(benzoyloxy)-1,3,4,7,8,9,9a,10,10a,12,12a,12b-dodecahydro-2-hydroxy-5,13,13-trimethyl-8-oxo-2,6-methano-2h-cyclodeca[3,4]cyclopropa[4,5]benz[1,2-b]oxet-4-yl Ester, (alphar,betas)-
7. (1s,2s,4s,7r,8ar,9as,10ar,12as,12br)-1-(benzoyloxy)-4-(((2r,3s)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-2-hydroxy-5,13,13-trimethyl-8-oxo-1,3,4,7,8,9,9a,10,10a,12b-decahydro-2h-2,6-methanocyclodeca[3,4]cyclopropa[4,5]benzo[1,2-b]oxete-7,12a(12h)-diyl Diacetate
8. Xrp 9881
9. Unii-twq8k8a81y
10. Pnu 100940
11. Benzenepropanoic Acid, Beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (1s,2s,4s,7r,8ar,9as,10ar,12as,12br)-7,12a-bis(acetyloxy)-1-(benzoyloxy)-1,3,4,7,8,9,9a,10,10a,12,12a,12b-dodecahydro-2-hydroxy-5,13,13-trimethyl-8-oxo-2,6-methano-2h-cyclodeca(3,4)cyclopropa(4,5)benz(1,2-b)oxet-4-yl Ester, (alphar,betas)-
12. Larotaxel [who-dd]
13. Schembl125697
14. Chembl4279455
15. Zinc95627892
16. Db12984
17. Pnu-100940
18. Hy-125374
19. Cs-0091011
20. Q6489757
21. [(1s,2s,3r,4s,7r,9s,11r,13r,16s)-4,13-diacetyloxy-1-hydroxy-16-[(2r,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-15,18,18-trimethyl-12-oxo-6-oxapentacyclo[12.3.1.03,11.04,7.09,11]octadec-14-en-2-yl] Benzoate
22. 1-hydroxy-9-oxo-5.beta.,20-epoxy-7.beta.,19-cyclotax-11-ene-2.alpha.,4,10.beta.,13.alpha.-tetrayl 4,10-diacetate 2-benzoate 13-((2r,3s)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate)
| Molecular Weight | 831.9 g/mol |
|---|---|
| Molecular Formula | C45H53NO14 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 15 |
| Exact Mass | 831.34660536 g/mol |
| Monoisotopic Mass | 831.34660536 g/mol |
| Topological Polar Surface Area | 210 Ų |
| Heavy Atom Count | 60 |
| Formal Charge | 0 |
| Complexity | 1790 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
89
PharmaCompass offers a list of Larotaxel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Larotaxel manufacturer or Larotaxel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Larotaxel manufacturer or Larotaxel supplier.
PharmaCompass also assists you with knowing the Larotaxel API Price utilized in the formulation of products. Larotaxel API Price is not always fixed or binding as the Larotaxel Price is obtained through a variety of data sources. The Larotaxel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Larotaxel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Larotaxel, including repackagers and relabelers. The FDA regulates Larotaxel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Larotaxel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Larotaxel supplier is an individual or a company that provides Larotaxel active pharmaceutical ingredient (API) or Larotaxel finished formulations upon request. The Larotaxel suppliers may include Larotaxel API manufacturers, exporters, distributors and traders.
Larotaxel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Larotaxel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Larotaxel GMP manufacturer or Larotaxel GMP API supplier for your needs.
A Larotaxel CoA (Certificate of Analysis) is a formal document that attests to Larotaxel's compliance with Larotaxel specifications and serves as a tool for batch-level quality control.
Larotaxel CoA mostly includes findings from lab analyses of a specific batch. For each Larotaxel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Larotaxel may be tested according to a variety of international standards, such as European Pharmacopoeia (Larotaxel EP), Larotaxel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Larotaxel USP).
